Morning Headlines 2/22/19
Allscripts announces fourth quarter and 2018 full-year results
Allscripts announces Q4 results: revenue up 17 percent, adjusted EPS $0.20 vs. $0.18, falling short of Wall Street expectations for both.
The FTC is in negotiations with Facebook over a multi-billion dollar fine that would put a stop to the agency’s nearly year-long investigation into the social media giant’s privacy practices.
China Uses DNA to Track Its People, With the Help of American Expertise
Thermo Fisher will stop selling its DNA testing equipment to China after discovering its government is secretly collecting the DNA of a predominantly Muslim ethic group and adding it to a surveillance database.
“She Never Looks Back”: Inside Elizabeth Holmes’s Chilling Final Months at Theranos
Vanity Fair recounts the icy atmosphere at Theranos during its final months, including the eerily chipper mood and lavish spending habits of CEO Elizabeth Holmes.
You know what will radically improve patient lives? Universal healthcare, access to housing, paid childcare, better public transport. Improve a…